Dare Bioscience, Inc. — Director's Dealing 2014

Apr 10, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2014-04-10

Reporting Person: FRIEDMAN PAUL A (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$10.59	2024-01-26	Common Stock (13786)		Direct

Footnotes

F1: This option was granted on January 27, 2014. This option vests in three equal annual installments on the first, second and third year anniversaries of the date that Mr. Friedman was elected to serve as a director of the Company. The option will fully vest as of January 27, 2017.

F2: Reflects a 1-for-14.5074 reverse stock split effected on March 31, 2014.